SPDR S&P Pharmaceuticals ETF
XPH
XPH
74 hedge funds and large institutions have $286M invested in SPDR S&P Pharmaceuticals ETF in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11.16% less ownership
Funds ownership: 70.43% → 59.26% (-11%)
14% less capital invested
Capital invested by funds: $332M → $286M (-$46.4M)
Holders
74
Holding in Top 10
2
Calls
$445K
Puts
$424K
Top Buyers
| 1 | +$8.26M | |
| 2 | +$4.33M | |
| 3 | +$2.47M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.38M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.02M |
Top Sellers
| 1 | -$36.8M | |
| 2 | -$34.4M | |
| 3 | -$1.24M | |
| 4 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
-$930K |
| 5 |
PG
PEAK6 Group
Chicago,
Illinois
|
-$680K |